Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124901) titled 'Efficacy evaluation of Letrozole Cotreatment with Progestin-primed Ovarian Stimulation in Women with Polycystic Ovary Syndrome Treated for IVF' on May 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Condition:
Polycystic Ovary Syndrome
Intervention:
Progestin-primed ovarian stimulation combined with letrozole group (PPOS+LE group):Participants received MPA and LE in combination with HMG for ovarian stimulation starting from menstrual cycle day 2-4, with the HMG dose adjusted according ...